iPSC-based immunotherapy
We are employing innovative Induced Pluripotent Stem Cells (iPSC)-based immunotherapies against aggressive forms of cancers to solve the three major hurdles associated with cancer treatment : treatment resistance, metastatic spread, and relapse.
iPSirius' proprietary IPVAC technology enables patient's immune system to specifically recognize and respond to thousands of antigens found in CSC while converting the tumor microenvironment from a state where the immune system is suppressed to a state where it becomes more active and responsive. This means shifting the conditions within the tumor to make it easier for the immune system to recognize and attack cancer cells. With IPVAC, we aim to enhance the body's natural defense mechanisms and improve the chances of effectively eradicating CSC, the root of cancer.
